Business Daily Media

Business Marketing

Novotech CRO strengthens South Korean Clinical Capabilities partnering with 2 Major Hospitals

  • Written by ACN Newswire
SYDNEY, Apr 18, 2019 - (ACN Newswire) - Novotech, the award-winning Asia-Pacific CRO with 23 years of experience in the region, has further strengthened its presence in South Korea with two major hospitals joining the Novotech partnership program - bringing more quality investigators, KOLs, and up to 4 million patients.

The 900 bed Ulsan University Hospital (UUH), and the Hepatology Division in Gastroenterology, Department of Internal Medicine at the 1,778 bed Seoul National University Hospital (SNUH), have joined the Novotech CRO partnership program, further strengthening Novotech's clinical service capabilities in South Korea.

South Korea is a fast-growing destination for clinical studies with quality infrastructure, world-class medical and hospital facilities, and supportive rapid start-up regulations. South Korea was Asia's most active country in clinical research after China last year, with over 400 sites opened by biopharma companies.

Novotech is well established in Asia with offices in 11 countries and more than 550 staff, while 19 leading hospitals and medical facilities across the region have now joined the Novotech CRO clinical partnership program.

Novotech CEO Dr John Moller said biotech clients were increasingly running Phase I studies in Australia, benefiting from the 41% R&D tax credit, then moving to Asia for subsequent trials. "Having the same company that understands the study as it transitions into Asia is always reassuring for clients. Novotech uses the latest Oracle and Medidata technology, so seamlessly connects with global clinical partners."

About Novotech - https://novotech-cro.com/welcome[1]Headquartered in Sydney, Novotech is internationally recognized as the leading regional full-service contract research organization (CRO). With a focus on clinical monitoring, Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials across the Asia Pacific region.

Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management.

For RFP enquiries: Please fill out the form available at www.novotech-cro.com/contact-us-0[2]

Media Contact:[email protected]Susan Fitzpatrick-Napier, AU: +61 2 8218 2144USA: +1 415 951 3228, Asia: +65 3159 3427 [3]

Topic: Press release summarySectors: HealthCare[4] http://www.acnnewswire.com From the Asia Corporate News Network

Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

References

  1. ^ https://novotech-cro.com/welcome (novotech-cro.com)
  2. ^ www.novotech-cro.com/contact-us-0 (www.novotech-cro.com)
  3. ^ [email protected] (www.acnnewswire.com)
  4. ^ HealthCare (www.acnnewswire.com)

Read more http://www.acnnewswire.com/press-release/english/51234/

Popular

Why outsourcing e-commerce activities can save your business up to 80 percent in costs

Online shopping hit new heights during the pandemic as people were forced to stay home. Many businesses that didn’t already have an online store were quick to adapt. E-commerce has totally revolutionised not just the way we shop...

7 Tips To Increase The Security Of Your Restaurant

Running a restaurant requires you to pay attention to all manner of details. From the decor and ambience, to the quality of food and level of service – all these different aspects are essential when cooking up a successful res...

Capgemini to acquire Australian cloud and digital services provider, Empired

The acquisition of Empired would significantly increase the size of the Capgemini business in Australia and New Zealand and position it as a market leader in digital, data and cloud across the region   Paris, Sydney, July 1...

Virtual Office
Tomorrow Business Growth